China Underground > All the latest news about China > China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover raises $230 million, plans vaccines for COVID-19 variants

Last Updated on 2021/02/22

China’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings, it said on Tuesday, as it …

Post Author

Enjoyed this post? Never miss out on future posts by following us

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

China Photography